|26.18||+0.0900||+0.34%||Vol 586.75K||1Y Perf -30.26%|
|Oct 4th, 2023 16:00 DELAYED|
|- -||- -%|
|Target Price||44.75||Analyst Rating||Strong Buy 1.30|
|Potential %||70.93||Finscreener Ranking||★★★★ 52.94|
|Insiders Trans % 3/6/12 mo.||-/-100/-100||Value Ranking||★★+ 48.28|
|Insiders Value % 3/6/12 mo.||-/-100/-100||Growth Ranking||★★ 46.23|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-100/-100||Income Ranking||— -|
|Price Range Ratio 52W %||26.93||Earnings Rating||Strong Sell|
|Market Cap||2.96B||Earnings Date||1st Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||1st Nov 2023|
|Estimated EPS Next Report||-0.01|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||737.98K|
|Avg. Monthly Volume||893.57K|
|Avg. Quarterly Volume||898.82K|
Evolent Health Inc Class A (NYSE: EVH) stock closed at 26.09 per share at the end of the most recent trading day (a -3.05% change compared to the prior day closing price) with a volume of 623.42K shares and market capitalization of 2.96B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 2900 people. Evolent Health Inc Class A CEO is Seth Blackley.
The one-year performance of Evolent Health Inc Class A stock is -30.26%, while year-to-date (YTD) performance is -7.09%. EVH stock has a five-year performance of -0.84%. Its 52-week range is between 21.8322 and 37.9799, which gives EVH stock a 52-week price range ratio of 26.93%
Evolent Health Inc Class A currently has a PE ratio of -169.40, a price-to-book (PB) ratio of 3.20, a price-to-sale (PS) ratio of 2.90, a price to cashflow ratio of 126.80, a PEG ratio of -, a ROA of -0.95%, a ROC of -0.41% and a ROE of -1.96%. The company’s profit margin is -0.81%, its EBITDA margin is 2.40%, and its revenue ttm is $969.58 Million , which makes it $9.58 revenue per share.
Of the last four earnings reports from Evolent Health Inc Class A, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.01 for the next earnings report. Evolent Health Inc Class A’s next earnings report date is 01st Nov 2023.
The consensus rating of Wall Street analysts for Evolent Health Inc Class A is Strong Buy (1.3), with a target price of $44.75, which is +70.93% compared to the current price. The earnings rating for Evolent Health Inc Class A stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Evolent Health Inc Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Evolent Health Inc Class A has a Sell technical analysis rating based on Technical Indicators (ADX : 11.60, ATR14 : 0.74, CCI20 : -10.42, Chaikin Money Flow : -0.01, MACD : 0.00, Money Flow Index : 71.31, ROC : -0.42, RSI : 44.18, STOCH (14,3) : 15.34, STOCH RSI : 0.00, UO : 50.61, Williams %R : -84.66), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Evolent Health Inc Class A in the last 12-months were: Blackley Seth (Option Excercise at a value of $426 394), Blackley Seth (Option Exercise at a value of $126 762), Blackley Seth (Sold 313 034 shares of value $10 223 589 ), Daniel Joseph Mccarthy (Sold 1 000 shares of value $31 440 ), Frank J. Williams (Option Excercise at a value of $3 173 548), Frank J. Williams (Sold 866 667 shares of value $27 347 420 ), Holder Diane (Sold 12 000 shares of value $375 120 ), Scott Cheryl (Sold 2 365 shares of value $70 974 ), Seth Blackley (Option Excercise at a value of $288 000), Seth Blackley (Sold 243 983 shares of value $7 844 404 ), Williams Frank (Option Excercise at a value of $4 149 344), Williams Frank (Sold 866 667 shares of value $28 248 448 ), WILLIAMS FRANK J (Option Exercise at a value of $1 064 896), WILLIAMS FRANK J (Sold 110 000 shares of value $3 247 108 )
Wed, 09 Aug 2023 02:25 GMT Evolent Health (EVH) Gets a Hold from Truist Financial- TipRanks. All rights reserved.
Sat, 05 Aug 2023 01:51 GMT Analysts Are Bullish on Top Healthcare Stocks: Evolent Health (EVH), Karuna Therapeutics (KRTX)- TipRanks. All rights reserved.
Fri, 07 Jul 2023 01:45 GMT Evolent Health (EVH) Receives a Buy from RBC Capital- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.